The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA)
Open accessAbstract
Non-small-cell lung cancer (NSCLC) represents a heterogeneous group of malignancies consisting essentially of adenocarcinoma (ADC) and squamous cell carcinoma (SCC). Although the diagnosis and treatment of ADC and SCC have been greatly improved in recent decades, there is still an urgent need to identify accurate transcriptome profile associated with the histological subtypes of NSCLC. The present study aims to identify the key dysregulated pathways and genes involved in the development of lung ADC and SCC and to relate them with the clinical traits. The transcriptional changes between tumour and normal lung tissues were investigated by RNA-seq. Gene ontology (GO), canonical pathways analysis with the prediction of upstream regulators, and weighted gene co-expression network analysis (WGCNA) to identify co-expressed modules and hub genes were used to explore the biological functions of the identified dysregulated genes. It was indicated that specific gene signatures differed significantly between ADC and SCC related to the distinct pathways. Of identified modules, four and two modules were the most related to clinical features in ADC and SCC, respectively. CTLA4, MZB1, NIP7, and BUB1B in ADC, as well as GNG11 and CCNB2 in SCC, are novel top hub genes in modules associated with tumour size, SUVmax, and recurrence-free survival. Our research provides a more effective understanding of the importance of biological pathways and the relationships between major genes in NSCLC in the perspective of searching for new molecular targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A. H., Tanaseichuk, O., Benner, C., & Chanda, S. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09234-6 · Cited by 14,611 · cited 2×
“Then, the optimal soft threshold for adjacency computation was graphically determined.”
InfluentialcytoHubba: identifying hub objects and sub-networks from complex interactome
Chin, C.-H., Chen, S.-H., Wu, H.-H., Ho, C.-W., Ko, M.-T., & Lin, C.-Y. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-s4-s11 · Cited by 6,562
Causal analysis approaches in Ingenuity Pathway Analysis
Krämer, A., Green, J., Pollard, J., & Tugendreich, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt703 · Cited by 5,724 · cited 1×
“The upstream regulator analysis tool is a function in IPA which may, using analysing linkage to DEGs through coordinated expression, identify assumed upstream regulators that have been observed experimentally to affect gene expression [34]. experimentally to a ect gene expression [34].”
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034 · cited 1×
“Since it is known that biological processes are based on the numerous interactions between many cellular components, gene network analysis could provide precious information on cancer pathogenesis [10].”
The biology and management of non-small cell lung cancer
Herbst, R. S., Morgensztern, D., & Boshoff, C. (2018) · Nature · doi:10.1038/nature25183 · Cited by 4,891 · cited 1×
“The main subtypes of NSCLC are squamous cell carcinoma (SCC), adenocarcinoma (ADC), and large-cell carcinoma (LCC) [2].”
Maere, S., Heymans, K., & Kuiper, M. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti551 · Cited by 4,155
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Wei, S. C., Duffy, C. R., & Allison, J. P. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0367 · Cited by 3,088
RSeQC: quality control of RNA-seq experiments
Wang, L., Wang, S., & Li, W. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts356 · Cited by 2,788
Herbst, R. S., Heymach, J. V., & Lippman, S. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0802714 · Cited by 2,389
CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition
Buchbinder, E. I., & Desai, A. (2016) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000239 · Cited by 2,360 · cited 1×
“For the red module, the highly connected hub gene was CTLA4, which is a member of the immunoglobulin superfamily and encodes a transmembrane protein which negatively regulates the T cell function [43].”
Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data
Okonechnikov, K., Conesa, A., & García-Alcalde, F. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btv566 · Cited by 2,145 · cited 1×
“1 [95], flagstat module from Samtools [96], and RSeQC [97].”
RNA sequencing: advances, challenges and opportunities
Ozsolak, F., & Milos, P. M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2934 · Cited by 2,135 · cited 1×
“However, the attempt to explain the complex relationship between genes is still a challenge [8,9].”
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Fast R Functions for Robust Correlations and Hierarchical Clustering
Langfelder, P., & Horvath, S. (2012) · Journal of Statistical Software · doi:10.18637/jss.v046.i11 · Cited by 1,279
Wnt/beta-catenin pathway: modulating anticancer immune response
Pai, S. G., Carneiro, B. A., Mota, J. M., Costa, R., Leite, C. A., Barroso-Sousa, R., Kaplan, J. B., Chae, Y. K., & Giles, F. J. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0471-6 · Cited by 703
Hayami, S., Kelly, J. D., Cho, H., Yoshimatsu, M., Unoki, M., Tsunoda, T., Field, H. I., Neal, D. E., Yamaue, H., Ponder, B. A. J., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25349 · Cited by 489 · cited 2×
“…tumorigenesis KDM1A , with the highest activation z-score, encodes lysine demethylase 1, which contributes to tumorigenesis in many types of cancer [38], while TP63 encodes p63 protein which is a master regulator in epithelial development and has shown significance in cancer progression [39]. in…”
Interleukin-1 Beta—A Friend or Foe in Malignancies?
Bent, R., Moll, L., Grabbe, S., & Bros, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082155 · Cited by 444
Fibroblast growth factor signaling in tumorigenesis
Grose, R., & Dickson, C. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.003 · Cited by 404
IL‐1 and IL‐1 regulatory pathways in cancer progression and therapy
Mantovani, A., Barajon, I., & Garlanda, C. (2018) · Immunological Reviews · doi:10.1111/imr.12614 · Cited by 376
The role of fibroblast growth factors and their receptors in prostate cancer
Kwabi-Addo, B., Ozen, M., & Ittmann, M. (2004) · Endocrine-Related Cancer · doi:10.1677/erc.1.00535 · Cited by 350
Wilkerson, M. D., Yin, X., Walter, V., Zhao, N., Cabanski, C. R., Hayward, M. C., Miller, C. R., Socinski, M. A., Parsons, A. M., Thorne, L. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036530 · Cited by 298
The MAGE protein family and cancer
Weon, J. L., & Potts, P. R. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.08.002 · Cited by 257
Macrophage migration inhibitory factor (MIF): A promising biomarker
Grieb, G., Merk, M., Bernhagen, J., & Bucala, R. (2010) · Drug News & Perspectives · doi:10.1358/dnp.2010.23.4.1453629 · Cited by 242
Extravasation of leukocytes in comparison to tumor cells
Strell, C., & Entschladen, F. (2008) · Cell Communication and Signaling · doi:10.1186/1478-811x-6-10 · Cited by 228
BUB1 and BUBR1: multifaceted kinases of the cell cycle
Bolanos-Garcia, V. M., & Blundell, T. L. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.08.004 · Cited by 223
Pardo, O. E., Wellbrock, C., Khanzada, U. K., Aubert, M., Arozarena, I., Davidson, S., Bowen, F., Parker, P. J., Filonenko, V. V., Gout, I. T., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601198 · Cited by 183
Identification of Key Pathways and Genes in the Dynamic Progression of HCC Based on WGCNA
Yin, L., Cai, Z., Zhu, B., & Xu, C. (2018) · Genes · doi:10.3390/genes9020092 · Cited by 168
Zhou, X., Huang, X., Liang, S., Tang, S., Wu, S., Huang, T., Mo, Z., & Wang, Q. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s163891 · Cited by 165
Schürch, D., Ospina, O. L., Cruz, A., & Pérez‐Gil, J. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.09.039 · Cited by 162
Faruki, H., Mayhew, G. M., Serody, J. S., Hayes, D. N., Perou, C. M., & Lai-Goldman, M. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.03.010 · Cited by 159
Wang, T.-Y., Chen, B., Yang, Y., Chen, H., Wang, Y., Čviko, A., Quade, B. J., Sun, D., Yang, A., McKeon, F., et al. (2001) · Human Pathology · doi:10.1053/hupa.2001.24324 · Cited by 150
Role of p63 in Development, Tumorigenesis and Cancer Progression
Bergholz, J. S., & Xiao, Z. J. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0116-9 · Cited by 129
Targeting HER2 Aberrations in Non–Small Cell Lung Cancer with Osimertinib
Liu, S., Li, S., Hai, J., Wang, X., Chen, T., Quinn, M. M., Gao, P., Zhang, Y., Ji, H., Cross, D. A. E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1875 · Cited by 129
Flach, H., Rosenbaum, M., Duchniewicz, M., Kim, S., Zhang, S. L., Cahalan, M. D., Mittler, G., & Grosschedl, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.013 · Cited by 128
Profiling cancer testis antigens in non–small-cell lung cancer
Djureinovic, D., Hallström, B. M., Horie, M., Mattsson, J. S. M., Fleur, L. L., Fagerberg, L., Brunnström, H., Lindskog, C., Madjar, K., Rahnenführer, J., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86837 · Cited by 127
High-throughput determination of RNA structure by proximity ligation
Ramani, V., Qiu, R., & Shendure, J. (2015) · Nature Biotechnology · doi:10.1038/nbt.3289 · Cited by 113
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription
Kanteti, R., Nallasura, V., Loganathan, S., Tretiakova, M., Kroll, T. G., Krishnaswamy, S., Faoro, L. N., Cagle, P. T., Husain, A. N., Vokes, E. E., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2008.168 · Cited by 111
ERBB2 -Mutated Metastatic Non–Small Cell Lung Cancer: Response and Resistance to Targeted Therapies
Chuang, J. C., Stehr, H., Liang, Y., Das, M. S., Huang, J. Q., Diehn, M., Wakelee, H. A., & Neal, J. W. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.01.023 · Cited by 102
Gentles, A. J., Bratman, S. V., Lee, L. J., Harris, J. P., Feng, W., Nair, R. V., Shultz, D. B., Nair, V. S., Hoang, C. D., West, R. B., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv211 · Cited by 97
Assembly of a parts list of the human mitotic cell cycle machinery
Giotti, B., Chen, S.-H., Barnett, M. W., Regan, T. W., Ly, T., Wiemann, S., Hume, D. A., & Freeman, T. C. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy063 · Cited by 92
Hsu, Y., Hung, J., Lee, Y., Chen, F.-W., Chang, K., Chang, W., Tsai, Y., Chong, I., & Kuo, P. (2017) · Oncotarget · doi:10.18632/oncotarget.21022 · Cited by 90
The Pax-5 Gene: A Pluripotent Regulator of B-cell Differentiation and Cancer Disease
O'Brien, P., Morin, P., Ouellette, R. J., & Robichaud, G. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1874 · Cited by 89
Identification of Prognostic Candidate Genes in Breast Cancer by Integrated Bioinformatic Analysis
Wang, C. C. N., Li, C., Cai, J.-H., Sheu, P. C. ‐., Tsai, J., Wu, M., Li, C., & Hou, M.-F. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081160 · Cited by 88
Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis
Gao, M., Kong, W., Huang, Z., & Xie, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082994 · Cited by 83
Languino, L. R., Singh, A., di Prisco, M., Inman, G. J., Luginbuhl, A., Curry, J., & South, A. P. (2016) · PubMed Central · Cited by 74
Egolf, S., Aubert, Y., Doepner, M., Anderson, A., López, A. M. M., Pacella, G., Lee, J., Ko, E. K., Zou, J., Lan, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.058 · Cited by 71
Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors
Hellwig, S. M. M., Damen, C. A., van Adrichem, N. P. H., Blijham, G. H., Groenewegen, G., & Griffioen, A. W. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00310-8 · Cited by 65
The paradoxical role of tumor-infiltrating immune cells in lung cancer
Zheng, X., Hu, Y., & Yao, C. (2017) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2017.01059 · Cited by 65
Stalberg, P. L. H., Grimfjärd, P., Santesson, M., Zhou, Y., Lindberg, D. M., Gobl, A., Öberg, K., Westin, G., Rastad, J., Wang, S., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031228 · Cited by 61
G-protein γ subunit GNG11 strongly regulates cellular senescence
Hossain, M. N., Sakemura, R., Fujii, M., & Ayusawa, D. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.112 · Cited by 57
Angiogenic Profile of Breast Carcinoma Determines Leukocyte Infiltration
Steege, J. C. A. B.-T., Baeten, C. I. M., Thijssen, V. L., Satijn, S., Verhoeven, I. C. L., Hillen, H. F. P., Wagstaff, J., & Griffioen, A. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0742 · Cited by 55
Yin, Y., Betsuyaku, T., Garbow, J. R., Miao, J., Govindan, R., & Ornitz, D. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0495 · Cited by 54
Ohue, Y., Kurose, K., Nozawa, R., Isobe, M., Nishio, Y., Tanaka, T., Doki, Y., Hori, T., Fukuoka, J., Oka, M., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0266 · Cited by 53
Choi, H., & Na, K. J. (2018) · Theranostics · doi:10.7150/thno.23767 · Cited by 52
Hu, C.-T., Guo, L., Feng, N., Zhang, L., Zhou, N., Ma, L., Shen, L., Tong, G., Yan, Q.-W., Zhu, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4198 · Cited by 50
KDM1A promotes tumor cell invasion by silencing TIMP3 in non-small cell lung cancer cells
Kong, L., Zhang, P., Li, W., Yang, Y., Tian, Y. E., Wang, X., Chen, S., Yang, Y., Huang, T., Zhao, T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8563 · Cited by 49
Kanda, M., Tanaka, C., Kobayashi, D., Tanaka, H., Shimizu, D., Shibata, M., Takami, H., Hayashi, M., Iwata, N., Niwa, Y., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30286 · Cited by 49
Li, B., Meng, Y., Li, Z., Yin, C., Lin, J.-P., Zhu, D., & Zhang, S.-B. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1648283 · Cited by 46
Shi, K., Li, N., Yang, M., & Li, W. (2018) · Journal of Cancer · doi:10.7150/jca.26908 · Cited by 44
Tumor‐specific antigens in cutaneous T‐cell lymphoma: Expression and sero‐reactivity
Eichmüller, S. B., Usener, D., Thiel, D., & Schadendorf, D. (2003) · International Journal of Cancer · doi:10.1002/ijc.10967 · Cited by 43
David, K. A., Unger, F. T., Uhlig, P. C., Juhl, H. H., Moore, H. M., Compton, C. C., Nashan, B., Dörner, A., de Weerth, A., & Zornig, C. (2014) · Oncotarget · doi:10.18632/oncotarget.2669 · Cited by 42
Keratinization of Lung Squamous Cell Carcinoma Is Associated with Poor Clinical Outcome
Park, H. J., Cha, Y. J., Kim, S., Kim, A., Kim, E. Y., & Chang, Y. S. (2017) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2017.80.2.179 · Cited by 41
Zhang, Y. Q., Zhang, J., Song, H., & Li, D. W. (2017) · Europe PMC (PubMed Central) · Cited by 34
Zhang, S., Zhai, X., Wang, G., Feng, J., Zhu, H., Xu, L., Mao, G., & Huang, J. (2015) · Europe PMC (PubMed Central) · Cited by 33
Tumor intrinsic immunity related proteins may be novel tumor suppressors in some types of cancer
Xiong, D., Wang, Y., & You, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-47382-3 · Cited by 33
Nikliński, J., Kretowski, A. J., Moniuszko, M., Reszeć, J., Michalska‐Falkowska, A., Niemira, M., Ciborowski, M., Charkiewicz, R., Jurgilewicz, D., Kozłowski, M., et al. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.05.002 · Cited by 30
Self-citationNakamura, H., Fujii, K., Gupta, V., Hata, H., Koizumu, H., Hoshikawa, M., Naruki, S., Miyata, Y., Takahashi, I., Miyazawa, T., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217105 · Cited by 30
Wu, Y., Su, L., Wang, H., Lin, C.-F. J., Hsu, W., Chou, T., Huang, C. F., Lu, C.-L., & Hsueh, C.-T. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181e2f4f5 · Cited by 29
Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC
Charkiewicz, R., Nikliński, J., Claesen, J., Sulewska, A., Kozłowski, M., Michalska‐Falkowska, A., Reszeć, J., Moniuszko, M., Naumnik, W., & Niklińska, W. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.01.015 · Cited by 28
FGF 19 genetic amplification as a potential therapeutic target in lung squamous cell carcinomas
Zhang, X., Kong, M., Zhang, Z., Xu, S., Yan, F., Wei, L., & Zhou, J. (2017) · Thoracic Cancer · doi:10.1111/1759-7714.12504 · Cited by 28
Tumor Pre-Analytics in Molecular Pathology: Impact on Protein Expression and Analysis
Neumeister, V. M., & Juhl, H. H. (2018) · Current Pathobiology Reports · doi:10.1007/s40139-018-0179-5 · Cited by 27
Shang, J., Wang, Z., Chen, W., Yang, Z., Zheng, L., Wang, S., & Li, S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28053 · Cited by 24
Peeters, C. F. J. M., Ruers, T. J. M., Westphal, J. R., & de Waal, R. M. W. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700217 · Cited by 23
Ni, Z., Wang, X., Zhang, T., Li, L., & Li, J. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.5833 · Cited by 23
BioBanking as the central tool for translational medicine CTM issue 2013
Marko‐Varga, G. (2013) · Clinical and Translational Medicine · doi:10.1186/2001-1326-2-4 · Cited by 20
Dave, M. N., Islam, A. B. M. M. K., Jensen, R. V., Rostagno, A. A., Ghiso, J. A., & Amin, A. R. (2017) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2017.03.005 · Cited by 10
Exploration of the hub genes and miRNAs in lung adenocarcinoma
Zhai, Y., Chen, Y., Li, Q., & Zhang, L.-Q. (2019) · Oncology Letters · doi:10.3892/ol.2019.10478 · Cited by 7
Expression Depression of CD300LG-γ in Human Pulmonary Carcinoma
Zhai, S., Xu, H., Jiang, X., Sun, S., Qin, L., Wei, D., & Hu, L. (2016) · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · doi:10.1089/mab.2015.0043 · Cited by 6
Cited by
Network Pharmacology Approach for Medicinal Plants: Review and Assessment
Noor, F., Tahir ul Qamar, M., Ashfaq, U. A., Albutti, A., Alwashmi, A. S. S., & Aljasir, M. A. (2022) · Pharmaceuticals · doi:10.3390/ph15050572 · Cited by 540
Shiridokht, F., Kehtari, P., Eskandani, M., Farajollahi, A., & Vandghanooni, S. (2025) · International Journal of Pharmaceutics: X · doi:10.1016/j.ijpx.2025.100419 · Cited by 4
Metadata
- Authors
- Niemira, M., Collin, F., Szalkowska, A., Bielska, A., Chwialkowska, K., Reszec, J., Niklinski, J., Kwasniewski, M., & Kretowski, A.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2019-12-21
- Volume
- 12
- Issue
- 1
- Pages
- 37
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2996118836
- Cited by
- 279
- References
- 86
- FWCI
- 15.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.